Moderna Inc (MRNA)
Moderna is a biotechnology company focusing on messenger RNA (mRNA) therapeutics and vaccines to create medicines. mRNA medicines are designed to direct the body's cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of diseases. Co. is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, autoimmune diseases and cardiovascular diseases. Co. has a collaboration agreement with the Institute of Life Changing Medicines to develop a mRNA therapeutic (mRNA-3351) for Crigler-Najjar Syndrome Type 1.
MRNA SEC Filing Email Alerts Service
| Company Name: |
Moderna Inc |
| Website: |
www.modernatx.com |
| Sector: |
Biotechnology |
| Number of ETFs Holding MRNA: |
110 |
| Total Market Value Held by ETFs: |
$8.49B |
| Total Market Capitalization: |
$74.17B |
| % of Market Cap. Held by ETFs: |
11.44% |
|
|
January 29, 2023 • 4:33 PM Eastern
Buy (2.92 out of 4)
20th percentile
|
|
Free MRNA Email Alerts:
